ADARx Pharmaceuticals Ord Shs (ADRX) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.62M	1.62M	2.14M	746.00K
Cost of goods sold	20.77M	20.77M	23.58M	24.74M
Cost of revenue	20.77M	20.77M	23.58M	24.74M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.52M	5.52M	5.62M	5.90M
Operating expense	5.52M	5.52M	5.62M	5.90M
Total operating expenses	26.30M	26.30M	29.20M	30.64M
Operating income	-24.68M	-24.68M	-27.06M	-29.89M
Other non operating income	505.50K	505.50K	411.00K	355.00K
EBT including unusual items	-19.72M	-19.72M	-22.67M	-25.76M
EBT excluding unusual items	-19.72M	-19.72M	-22.67M	-25.76M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-19.72M	-19.72M	-22.67M	-25.76M
Net profit margin	-1,217.03%	-1,217.03%	-1,059.21%	-3,452.95%
Earnings per share	-	-	-	-
Interest and investment income	4.45M	4.45M	3.98M	3.78M
Interest expense	-	-	-	-
Net interest expenses	4.45M	4.45M	3.98M	3.78M
Depreciation and amortization charges	-	-	-	-
EBITDA	-24.39M	-24.39M	-26.76M	-29.58M
Gain or loss from assets sale	-	-	-	-

Finance